#relapses — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #relapses, aggregated by home.social.
-
Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
Sanofi Winthrop Industrie Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for …
#France #FR #Europe #EU #Sanofi #clinicalstudy #disability #liverenzymeelevations #phase3studies #progressivemultiplesclerosis #relapses #TheEuropeanCommission
https://www.europesays.com/france/43111/ -
Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disabil…
#France #FR #Europe #EU #Sanofi #approved #as #Cenrifki #disability-targeting #first #for #in #Medicine #multiple #press #progressive #relapses #release #Sanofi’s #sclerosis #secondary #the #tolebrutinib #Without
https://www.europesays.com/france/39708/ -
https://www.europesays.com/ch/53754/ Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD #68% #become #by #demonstrating #ENSPRYNG #first #for #MOGAD #of #potential #reduces #relapses #Risk #Roche #Roche’s #satralizumab #to #treatment